Currently out of the existing stock ratings of Jason Zhuang, 4 are a BUY (100%).
Analyst Jason Zhuang, currently employed at LEERINK, has had 66.67% of price targets met with an average potential upside of 60.25%, reached in 463 days on average.
Jason Zhuang has documented 7 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on XOMA, XOMA Corp at 24-Feb-2026.
Analyst best performing recommendations are on XOMA (XOMA CORP).
The best stock recommendation documented was for XOMA (XOMA CORP) on 12/11/2025. The price target of $45 was fulfilled within 209 days with a profit of $18.46 (69.56%), with a performance score of 3.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2017
$39
$-1.17 (-2.91%)
$97
6 months 22 days ago
(30-Apr-2026)
1/28 (3.57%)
$-1.94 (-4.74%)
1154
Buy Since 29-Apr-2024
$50
$9.83 (24.47%)
$45
8 months 28 days ago
(24-Feb-2026)
2/3 (66.67%)
$22.96 (84.91%)
463
Buy Since 09-Sep-2025
$50
$35
1 years 2 months 12 days ago
(09-Sep-2025)
1/2 (50%)
$13.24 (36.02%)
140
Buy Since 07-Sep-2021
$22
$19
5 years 2 months 14 days ago
(07-Sep-2021)
5/6 (83.33%)
$-3.26 (-12.91%)
196
Hold Since 10-Mar-2016
$40
$40
10 years 8 months 11 days ago
(10-Mar-2016)
2/2 (100%)
$20.8 (108.33%)
1856
What Year was the first public recommendation made by Jason Zhuang?